Aidar Health, Inc

Aidar Health designs and develops clinically validated digital medicine software platforms and breath- and saliva-based biosensors for precision disease management across therapeutic areas including respiratory, renal, infectious, cardiovascular, and oncology. The company operates three primary product lines: Aidar Connect (clinician web application for remote patient monitoring and care coordination), MouthLab (medical device for biosensor data collection), and Aidar Care (patient mobile application). Aidar serves multiple market segments through specialized service offerings: Long-Term Care (remote physiological monitoring, chronic care management, transitional care management, hospital-at-home programs); Life Sciences (digital biomarkers, digital companions, decentralized clinical trials, real-world evidence collection); and Population Health Management for payers. The platform enables objective, non-invasive assessment of clinical status, facilitates early disease detection, supports treatment optimization, and enables risk stratification to reduce readmissions and emergency department utilization. Aidar has received FDA clearance for its breath-based medical device and maintains partnerships with major research institutions (NIH, Johns Hopkins, VA) and government agencies (BARDA, NSF). The company targets clinical outcomes improvement and cost reduction through digital-first precision medicine approaches suitable for aging populations and chronic disease management.